Search

Wu Cheng Winston Shen

Supervisory Patent Examiner (ID: 7676, Phone: (571)272-3157 , Office: P/1628 )

Most Active Art Unit
1632
Art Unit(s)
1632, 1682, 1621, 1628, 1634
Total Applications
384
Issued Applications
62
Pending Applications
85
Abandoned Applications
246

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20393489 [patent_doc_number] => 20250368964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => METHOD FOR CULTURING PRIMARY CANCER CELLS THROUGH SIMULATED MICROGRAVITY-INDUCED REPROGRAMMING AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 19/181736 [patent_app_country] => US [patent_app_date] => 2025-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7837 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19181736 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/181736
Method for culturing primary cancer cells through simulated microgravity-induced reprogramming and applications thereof Apr 16, 2025 Issued
Array ( [id] => 19512348 [patent_doc_number] => 20240344034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => Renal Progenitor Cells [patent_app_type] => utility [patent_app_number] => 18/757662 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757662 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/757662
Renal Progenitor Cells Jun 27, 2024 Pending
Array ( [id] => 19709514 [patent_doc_number] => 20250019656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS [patent_app_type] => utility [patent_app_number] => 18/744550 [patent_app_country] => US [patent_app_date] => 2024-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744550 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/744550
COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS Jun 13, 2024 Pending
Array ( [id] => 19543381 [patent_doc_number] => 20240360417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME [patent_app_type] => utility [patent_app_number] => 18/631774 [patent_app_country] => US [patent_app_date] => 2024-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631774 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/631774
CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME Apr 9, 2024 Pending
Array ( [id] => 19417661 [patent_doc_number] => 20240293784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => Thermo-induced stimuli-responsive membrane for leukocyte enrichment and application thereof [patent_app_type] => utility [patent_app_number] => 18/582695 [patent_app_country] => US [patent_app_date] => 2024-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582695 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/582695
Thermo-induced stimuli-responsive membrane for leukocyte enrichment and application thereof Feb 20, 2024 Pending
Array ( [id] => 19991109 [patent_doc_number] => 20250129331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => MEDIUM COMPOSITION FOR CULTURE OF EXTRAEMBRYONIC ENDODERM STEM CELLS [patent_app_type] => utility [patent_app_number] => 18/694319 [patent_app_country] => US [patent_app_date] => 2023-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694319 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/694319
MEDIUM COMPOSITION FOR CULTURE OF EXTRAEMBRYONIC ENDODERM STEM CELLS Jul 3, 2023 Pending
Array ( [id] => 18610728 [patent_doc_number] => 20230277458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY [patent_app_type] => utility [patent_app_number] => 18/195223 [patent_app_country] => US [patent_app_date] => 2023-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5621 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195223 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/195223
COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY May 8, 2023 Pending
Array ( [id] => 18469168 [patent_doc_number] => 20230203452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS [patent_app_type] => utility [patent_app_number] => 18/171832 [patent_app_country] => US [patent_app_date] => 2023-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171832 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/171832
METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS Feb 20, 2023 Pending
Array ( [id] => 19800797 [patent_doc_number] => 20250066722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS [patent_app_type] => utility [patent_app_number] => 18/703641 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703641 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/703641
METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS Nov 9, 2022 Pending
Array ( [id] => 18583134 [patent_doc_number] => 20230265393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS [patent_app_type] => utility [patent_app_number] => 17/935135 [patent_app_country] => US [patent_app_date] => 2022-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/935135
COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS Sep 25, 2022 Pending
Array ( [id] => 19541794 [patent_doc_number] => 20240358830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES [patent_app_type] => utility [patent_app_number] => 18/684155 [patent_app_country] => US [patent_app_date] => 2022-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684155 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/684155
ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES Aug 18, 2022 Pending
Array ( [id] => 18166269 [patent_doc_number] => 20230032871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => Recombinant Viral Particle for Gene and/or Cellular Therapy [patent_app_type] => utility [patent_app_number] => 17/812521 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812521 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812521
Recombinant Viral Particle for Gene and/or Cellular Therapy Jul 13, 2022 Abandoned
Array ( [id] => 17982847 [patent_doc_number] => 20220348883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => HIGH-DENSITY CELL CULTURE METHOD [patent_app_type] => utility [patent_app_number] => 17/863785 [patent_app_country] => US [patent_app_date] => 2022-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863785 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/863785
HIGH-DENSITY CELL CULTURE METHOD Jul 12, 2022 Pending
Array ( [id] => 18140342 [patent_doc_number] => 20230014181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/842715 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842715
CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS Jun 15, 2022 Pending
Array ( [id] => 18077728 [patent_doc_number] => 20220403340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 17/839138 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839138
MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME Jun 12, 2022 Pending
Array ( [id] => 18751576 [patent_doc_number] => 20230354789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE [patent_app_type] => utility [patent_app_number] => 17/924687 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924687
INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE May 25, 2022 Pending
Array ( [id] => 18160467 [patent_doc_number] => 20230027059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS [patent_app_type] => utility [patent_app_number] => 17/748323 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748323 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748323
METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS May 18, 2022 Pending
Array ( [id] => 18628487 [patent_doc_number] => 20230287352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR NON-ENZYMATIC 3D CULTURE AND AMPLIFICATION OF MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/739127 [patent_app_country] => US [patent_app_date] => 2022-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739127 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/739127
Method for non-enzymatic 3D culture and amplification of mesenchymal stem cells May 7, 2022 Issued
Array ( [id] => 18285863 [patent_doc_number] => 20230101335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/738843 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/738843
EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF May 5, 2022 Pending
Array ( [id] => 17657370 [patent_doc_number] => 20220177835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS [patent_app_type] => utility [patent_app_number] => 17/681113 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681113
METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS Feb 24, 2022 Pending
Menu